KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Finished Goods: 2011-2012

Historic Finished Goods for Pacira BioSciences (PCRX) over the last 2 years, with Dec 2012 value amounting to $2.0 million.

  • Pacira BioSciences' Finished Goods fell 5.81% to $4.3 million in Q2 2013 from the same period last year, while for Jun 2013 it was $4.3 million, marking a year-over-year decrease of 5.81%. This contributed to the annual value of $2.0 million for FY2012, which is 602.79% up from last year.
  • Pacira BioSciences' Finished Goods amounted to $2.0 million in FY2012, which was up 602.79% from $287,000 recorded in FY2011.
  • Pacira BioSciences' Finished Goods' 5-year high stood at $2.0 million during FY2012, with a 5-year trough of $287,000 in FY2011.
  • Moreover, its 2-year median value for Finished Goods was $1.2 million (2011), whereas its average is $1.2 million.
  • Data for Pacira BioSciences' Finished Goods shows a peak YoY skyrocketed of 602.79% (in 2012) over the last 5 years.
  • Over the past 2 years, Pacira BioSciences' Finished Goods (Yearly) stood at $287,000 in 2011, then surged by 602.79% to $2.0 million in 2012.